Eupraxia Pharmaceuticals Inc
TSX:EPRX

Watchlist Manager
Eupraxia Pharmaceuticals Inc Logo
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Watchlist
Price: 10 CAD 3.09%
Market Cap: 506.5m CAD

Relative Value

There is not enough data to reliably calculate the relative value of EPRX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EPRX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.8
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-3.9
Industry
24.1
Forward
-11.9
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-6
Industry
21.8
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-5.5
Industry
23.8
vs History
52
vs Industry
4
Median 3Y
8.2
Median 5Y
6.1
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
vs Industry
Median 3Y
-5
Median 5Y
-3.5
Industry
6.3
Forward
-11.6
vs History
vs Industry
Median 3Y
-5
Median 5Y
-3.5
Industry
6.7
Forward
-10
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-4.6
Industry
7.9
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-4.6
Industry
6.3
vs History
vs Industry
Median 3Y
-109.1
Median 5Y
-51.6
Industry
5.5

Multiples Across Competitors

EPRX Competitors Multiples
Eupraxia Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Eupraxia Pharmaceuticals Inc
TSX:EPRX
506m CAD 0 -17.2 -14.8 -14.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 623 419.7 -159 807.1 -194 056.8 -191 842.4
US
Abbvie Inc
NYSE:ABBV
407.2B USD 6.8 173.2 16.7 23.8
US
Amgen Inc
NASDAQ:AMGN
177.9B USD 5 25.5 18.3 18.3
US
Gilead Sciences Inc
NASDAQ:GILD
155.5B USD 5.4 19.3 12.9 12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.3B USD 10 32 23.4 24.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 095.2 -534.6 -582.2 -566.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.2B USD 5.8 18.2 17.4 19.7
AU
CSL Ltd
ASX:CSL
83B AUD 3.6 18.5 12.5 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.8B USD 16.4 1 211.1 163.3 198.1
NL
argenx SE
XBRU:ARGX
44B EUR 14.4 33.8 58.3 59.9
P/E Multiple
Earnings Growth PEG
CA
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Average P/E: 191.4
Negative Multiple: -17.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 807.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
173.2
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.5
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.3
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.2
9%
2
AU
CSL Ltd
ASX:CSL
18.5
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 211.1
N/A N/A
NL
argenx SE
XBRU:ARGX
33.8
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Average EV/EBITDA: 40.4
Negative Multiple: -14.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 056.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -582.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.4
11%
1.6
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.3
N/A N/A
NL
argenx SE
XBRU:ARGX
58.3
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Average EV/EBIT: 46.6
Negative Multiple: -14.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 842.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.3
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.7
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198.1
N/A N/A
NL
argenx SE
XBRU:ARGX
59.9
N/A N/A